Drugs / Alantel
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04116151 | Jul 2022 → May 2023 | radiodermatitis | Hospital Universitario Reina Sofia de Cordoba | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Alantel | “Alantel® is a cream developed to reduce redness and irritation, promote the local immune system, combat immunosenescence, and promote the healing of epidermal lesions.” PMID 38273379 ↗ Jan 2024 |
| Known as | Alantel (R) | “Cosmetic cream (Alantel (R): aloe vera, chamomile and thime)” NCT04116151 ↗ |
| Route | Topical | “Local administration of the Alantel (R) cream on the affected skin” NCT04116151 ↗ |